Figure 7 shows that the expression level of CAPG, RRM2, and SLC3A2 was higher whereas that of SLC2A12, CDO1, JDP2, MAFG, SLC2A3, VDAC2, GCH1, and ANGPTL7 was lower in bladder cancer tissue compared with the adjacent tissue. This evidence concerns the gene CDO1 and urinary bladder cancer.